|
|
| Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk | Successful clinical trials are crucial for advancing a novel therapeutic to market and maintaining a competitive edge. Clinical trials face risks such as supply shortages which can cause costly delays and impact the safety and well-being of the patients involved in the trial. Learn about strategies that can help build an understanding of risk assessment when developing a clinical supply plan with this on demand webinar. |
|
|
|
|
By Kristel Rens, director, business transformation & innovation, clinical supply chain, J&J Innovative Medicine | Why should pharma companies strive for more sustainable clinical trials? And how can digitalizing drug forecasting reduce waste in the supply chain? J&J Innovative Medicine's Kristel Rens explains. |
|
|
|
|
| Risk Mitigation In Direct-To-Patient Clinical Trials | Article | By Nicole Gray, Catalent | The DTP model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to study timelines and budgets. Explore how to ease trial troubles through DTP. |
|
|
|
|
|
|
|
|
.png){kind=logo}
